Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England.

BACKGROUND: In England, the reopening of universities in September 2020 coincided with a rapid increase in SARS-CoV-2 infection rates in university aged young adults. This study aimed to estimate SARS-CoV-2 antibody prevalence in students attending universities that had experienced a COVID-19 outbreak after reopening for the autumn term in September 2020.
METHODS: A cross-sectional serosurvey was conducted during 02-11 December 2020 in students aged ≤ 25 years across five universities in England. Blood samples for SARS-CoV-2 antibody testing were obtained using a self-sampling kit and analysed using the Abbott SARS-CoV-2 N antibody and/or an in-house receptor binding domain (RBD) assay.
FINDINGS: SARS-CoV-2 seroprevalence in 2,905 university students was 17.8% (95%CI, 16.5-19.3), ranging between 7.6%-29.7% across the five universities. Seropositivity was associated with being younger likely to represent first year undergraduates (aOR 3.2, 95% CI 2.0-4.9), living in halls of residence (aOR 2.1, 95% CI 1.7-2.7) and sharing a kitchen with an increasing number of students (shared with 4-7 individuals, aOR 1.43, 95%CI 1.12-1.82; shared with 8 or more individuals, aOR 1.53, 95% CI 1.04-2.24). Seropositivity was 49% in students living in halls of residence that reported high SARS-CoV-2 infection rates (>8%) during the autumn term.
INTERPRETATION: Despite large numbers of cases and outbreaks in universities, less than one in five students (17.8%) overall had SARS-CoV-2 antibodies at the end of the autumn term in England. In university halls of residence affected by a COVID-19 outbreak, however, nearly half the resident students became infected and developed SARS-CoV-2 antibodies. Crown

Background

Young adults have the highest rates of SARS-CoV-2 infection but rarely develop severe COVID-19, require hospitalisation, intensive care admission, or die of the infection. Consequently, university students are expected to have mild transient illness if infected with SARS-CoV-2. Given the close proximity of many university students living in high-density residential housing and their extensive connected social networks compared to the general population, the potential for rapid spread of SARS-CoV-2 in university settings is of concern. In England, this concern was reaffirmed by the large numbers of PCR-confirmed cases and outbreaks in young adults when universities reopened in September 2020. PCR-testing was widely available for students when the universities reopened but only recommended for individuals with characteristic symptoms of COVID-19 (fever, new onset of cough, loss of smell or taste) and would, therefore, miss asymptomatic, atypical and mildly symptomatic infections. Testing also require the students to attend community testing centres when they are symptomatic. In contrast to PCR testing which only provide a point estimate of symptomatic disease prevalence, serum antibodies provide a more accurate estimate of prior infection and extent of transmission during outbreaks in institutional settings, as has been demonstrated previously in care homes, for example.

In England and elsewhere, large number of outbreaks have been reported in universities and, because of public health concerns about asymptomatic infections fuelling these outbreaks and potentially contributing to wider community transmission, Public Health England (PHE) initiated a rapid serological evaluation of SARS-CoV-2 antibodies in universities across England that had experienced a COVID-19 outbreak to assess the extent of infection and transmission, the scale of outbreaks and risk factors for SARS-CoV-2 infection among university students. The findings of this serosurveillance will provide valuable information on the potential risk of future infections and outbreaks and implications for outbreak management and control in university settings.

Methods

Study design

PHE conducted a cross-sectional serosurvey during 2–11 December 2020 to estimate the prevalence of SARS-CoV-2 antibodies in students attending the following five universities across England: Leeds Beckett University, Newcastle University, University of Manchester, Oxford Brookes University and Reading University. The serosurvey was initiated rapidly after reports of large outbreaks in English universities, at a time when universities were implementing mass SARS-CoV-2 rapid testing programmes, just before the end of the autumn term (September to December 2020). All participating universities had reported an outbreak of COVID-19 to PHE between September and November 2020 (Supplementary Table 1).

Participants

University students aged 25 years or under who were enrolled with the university during the 2020/2021 academic year were invited to participate by email from the university or recruited by a PHE representative on-site on the day of mass lateral flow device (LFD) testing, along with invitation posters around the campus (Supplementary Table 1). Students were eligible to participate irrespective of whether they had prior confirmed COVID-19 or COVID-19 related symptoms.

Data sources

Participants provided online consent and completed a short online questionnaire. Information was collected on demographics, COVID-19 related illness or symptoms; accommodation type; whether they were aware of confirmed cases within their accommodation; and their participation in COVID-19 vaccine or other COVID-19 trials. Additional data were requested from universities regarding number of COVID-19 cases during the autumn term and occupancy of specific halls of residence within the university, which were verified through university and private accommodation provider websites.

Community seroprevalence estimates were obtained from the NHS Blood and Transplant (NHSBT) serological surveillance coordinated by PHE, which provides age-stratified seroprevalence across different geographic regions by testing samples from healthy adult blood donors using the Euroimmun Spike based assay.

Laboratory testing

Following online consent and questionnaire completion, participating students provided a blood sampling using the TASSO-SST OnDemand device to collect about 400 μL of capillary blood. The students were provided a TASSO kit containing the Tasso device, instructions, an alcohol swab and a plaster. The TASSO-SST OnDemand device attaches to the skin on the upper arm with a light adhesive. When the button is pressed, a vacuum forms and a lancet pricks the surface of the skin. The vacuum draws blood out of the capillaries and into a serum separator tube attached to the bottom of the Tasso Button. The blood sample is collected within 5 min and the device is removed from the arm. The blood-filled tube is then capped and sent to PHE for SARS-CoV-2 antibody testing by post (using the packaging and pre-paid envelope provided) or through courier collection from designated collection points at each university site.

At PHE, the samples were centrifuged, and sera tested for SARS-CoV-2 antibodies using the Abbott Architect SARS-CoV-2 IgG (nucleoprotein assay). The Abbot is highly specific (99.9%, 95% CI: 99.4–100; cut 0.8) and sensitive (92.7%,95% CI: 90.2–94.8), especially within the first three months after infection. Sera with insufficient volume for the Abbott assay were tested using a PHE in house receptor binding domain (RBD) assay (specificity 98.1%, 95% CI 97.3–98.8%; sensitivity 89.8%, 95%CI, 86.0–92.9). Results of the antibody testing were reported back to individual participants.

Statistical analyses

Data are mainly descriptive and presented as numbers and percentages. Tests for association with SARS-CoV-2 antibody positivity were performed using a mixed-effects logistic regression model, which allows for differences across the universities with the aim of making results generalisable to the student population. A multivariable model to explore demographic factors was fitted adjusting for sex, age group, ethnicity and accommodation type. Being unwell with COVID-19 symptoms and having a confirmed COVID-19 case in their accommodation were assessed in a mixed-effects regression models that accounted for university as a random effect.

Data for healthy blood donors aged 17–24 years, by region in England during Week 46 -Week 51 from the NHSBT serological collection were used to compare university seropositivity estimates to corresponding regional seropositivity estimates.

Sub-group analyses were conducted on those living in halls of residence, where data were available on resident occupancy and capacity of the hall, with the aim of exploring the effects of demographic factors and accommodation characteristics on SARS-CoV-2 antibody seropositivity. Both univariable and multivariable hierarchical mixed effects models were fitted, including individual hall of residence nested within the university. Factors explored were sex, age group, ethnicity, hall size and sharing facilities. Analyses were conducted using Stata v.15.0 (Statacorp, Tx).

Ethics approval

The study protocol was approved by the PHE Research Ethics and Governance Group – NR0245.

Funding

This study was funded by Public Health England. The authors had sole responsibility for the study design, data collection, data analysis, data interpretation, and writing of the report. The authors are all employed by PHE, the study funder, which is a public body — an executive agency of the Department of Health and Social Care.

Results

In total, 4873 students completed the online questionnaire but 85 were excluded because they were outside the specified age-range. Of the remaining 4788 participants, 2913 returned a blood sample with participant identifiable information (Fig. 1 ). Eight (0.3%) samples had insufficient volume for testing using either assay. Thus, 2905 were included in the final analysis, including 2702 (93%) with sufficient sample for testing with the Abbott assay and 203 (7%) with insufficient serum for the Abbott assay were tested using the RBD assay.

Fig. 1

. Flow diagram for study participants. The number of study participants (n) are provided. Reasons for exclusion are given.

Of the 2905 participants, 2565 (88.3%) were white and 1818 were female (62.6%). The median age of participants was 20 (IQR, 19–21) years. In total, 872 participants (30.0%) lived in halls of residence and 387/872 (44.4%) reported a confirmed COVID-19 case in their accommodation. At the same time, 2033 (70.0%) lived in other residential settings and 479 (23.6%) reported a confirmed COVID-19 case in their accommodation (Table 1 ). The characteristics of study participants in individual university are summarised in Supplementary Table 2.

Table 1

Characteristics of study participants – overall and stratified by valid and matched antibody test result.

Characteristics	Totaln (%)	Seropositiven (%)
Overall	2905 (100)	518 (17.8)
Gender
Male	1074 (37)	203 (18.9)
Female	1818 (62.6)	313 (17.2)
Prefer not to say	13 (0.5)	2 (15.4)
Age group
17–19	892 (30.7)	261 (29.3)
20–22	1739 (59.9)	231 (13.3)
23–25	274 (9.4)	26 (9.5)
Ethnicity
White	2565 (88.3)	462 (18)
Black	36 (1.2)	6 (16.7)
Asian	157 (5.4)	23 (14.6)
Mixed	122 (4.2)	23 (18.9)
Other	25 (0.9)	4 (16)
Medical condition (self-report)
Yes	418 (14.4)	62 (14.8)
No	2459 (84.6)	453 (18.4)
Unknown	28 (1)	3 (10.7)
Living in halls of residence
Halls of residence	872 (30.0)	252 (28.9)
Non- Halls of residence	2033 (70.0)	266 (13.1)
Accommodation type
Halls of residence	872 (30.0)	252 (28.9)
Off-campus housing	1922 (66.2)	250 (13)
Family Home	110 (3.8)	15 (13.6)
Other	1 (0.03)	1 (100)
Symptoms at any time since 1st Jan 2020
Symptomatic	1006 (34.6)	305 (30.3)
No symptoms	1589 (54.7)	130 (8.2)
Not known	310 (10.7)	36 (11.6)
Symptomatic after starting university (of those symptomatic)	553 (55)	244 (44.1)
Previous PCR positive (self-report)
Previous PCR positive	241 (8.3)	199 (82.6)
Reported no previous PCR positive	2664 (91.7)	319 (12.0)
Previous PCR positive Sept – Nov 2020	216 (7.4)	183 (84.7)
Confirmed case in accommodation
Confirmed case	866 (29.8)	310 (35.8)
No confirmed case	1874 (64.5)	186 (9.9)
Not Known	165 (5.7)	22 (13.3)
University
University A	500 (17.2)	80 (16)
University B	445 (15.3)	132 (29.7)
University C	784 (27.1)	143 (18.2)
University D	546 (18.8)	115 (21.1)
University E	630 (21.7)	48 (7.6)

The characteristics of students who completed the online questionnaire but didn't provide a blood sample with participant identifiable information (n = 1875) were generally similar to those who did return a sample (median age 21 (IQR 20–22) years, 1229 (65.6%) were female, 1613 (86.0%) were white and 512 (27.3%) individuals lived in halls of residence).

Seroprevalence of SARS-CoV-2 antibodies in university and community settings

In total, 518/ 2905 participants (17.8%; 95%CI, 16.5–19.3%) were seropositive for SARS-CoV-2 IgG. This compares with 13.7% (95% CI 11.1–16.9%), amongst healthy blood donors aged 17–24 years in England during calendar Weeks 46 to 51. Seropositivity varied across the five universities, ranging from 7.6% to 29.7% (Table 1). Seropositivity in University A, B and D was higher compared to their respective regional community blood donor seroprevalence, but this was not statistically significant (Fisher's Exact p > 0.05) (Fig. 2 , Supplementary Table 3).

Fig. 2

. University seropositivity by regional community blood donor seroprevalence estimates.

Previous COVID-19 history

Overall, 1006 (34.6%) participants reported COVID-19 related symptoms since 01 January 2020, including 553 (55% of those with COVID-19 symptoms; 19.0% of all participants) with symptom onset after starting university in the autumn term. Seropositivity was higher in participants reporting COVID-19 symptoms after starting university (244/553; 44.1% seropositive, 95% CI 39.9–48.4) compared to those who experienced symptoms prior to university (89/453; 19.7% seropositive, 95% CI 16.1–23.6). Among the 1589 participants who reported no COVID-19 related symptoms, 130 (8.2%) were seropositive.

Additionally, of 241 participants who reported a positive SARS-CoV-2 PCR test, 216 reported that the PCR test had been performed test during the autumn term (between September and November 2020), and 84.7% (183/216) were seropositive (Supplementary Table 4).

Factors associated with seropositivity in university students

In the univariate analysis, students aged 17–19 years had 4.1 times (95% CI, 2.7–6.4) greater odds of being seropositive than 23–25-year-olds, while those living in halls of residence had 2.9 times (95% CI, 2.4–3.5) greater odds of testing seropositive than those living in other accommodation types. In shared accommodation settings, having a confirmed case within the accommodation setting was significantly associated with seropositivity (OR 4.5, 95%CI 3.7–5.6). These associations remained independently significant in the multivariable logistic regression model (Table 2 ).

Table 2

Potential risk factors for antibody positivity for students.

Variable	Seropositiven/N (%)	Univariable regression OR (95% CI)	P value	Multivariable regressionaOR (95% CI)	Adjusted P value
Gender
Male	203/1074 (18.9)	Ref		Ref
Female	313/1818 (17.2)	0.87(0.71–1.06)	0.16	0.83(0.68–1.02)	0.08
Prefer not to say	2/13 (15.4)	0.63(0.14–2.89)	0.55	0.71(0.15–3.36)	0.67
Age group
23–25	26/274 (9.5)	Ref		Ref
20–22	231/1739 (13.3)	1.59(1.03–2.45)	0.04	1.67(1.08–2.57)	0.02
17–19	261/892 (29.3)	4.11(2.66–6.35)	<0.01	3.16(2.02–4.93)	<0.01
Ethnicity
White	462/2565 (18)	Ref		Ref
Black	6/36 (16.7)	1.05(0.42–2.6)	0.92	0.88(0.35–2.24)	0.79
Asian	23/157 (14.6)	0.82(0.51–1.29)	0.39	0.7(0.44–1.12)	0.14
Mixed	23/122 (18.9)	1.09(0.68–1.75)	0.73	1.02(0.63–1.67)	0.93
Other	4/25 (16)	0.93(0.31–2.78)	0.90	0.73(0.24–2.27)	0.59
Living in halls of residence
Non- Halls of residence	266/2033 (13.1)	Ref		Ref
Halls of residence b	252/872 (28.9)	2.89(2.36–3.54)	<0.01	2.14(1.7–2.68)	<0.01
Accommodation type
Off-campus housing	250/1922 (13)	Ref		Ref
Halls of residence	252/872 (28.9)	2.87(2.33–3.52)	<0.01	2.13(1.69–2.68)	<0.01
Family Home	15/110 (13.6)	0.83(0.47–1.48)	0.53	0.88(0.49–1.58)	0.66
Other	1/1 (100)	–	–	–	–
Sharing facilities
Sharing bedroom
No	493/2686 (18.4)	Ref		Ref
Yes	20/195 (10.3)	0.5(0.31–0.8)	<0.01	0.73(0.45–1.19)	<0.01
Unknown	5/24 (20.8)	–	–	–	–
Sharing bathroom
No	214/747 (28.6)	Ref		Ref
Yes	304/2158 (14.1)	0.43(0.35–0.53)	<0.01	0.73(0.57–0.95)	<0.01
No. of individuals student shares kitchen with
0–3	119/949 (12.5)	Ref		Ref
4–7	332/1657 (20)	1.92(1.53–2.42)	<0.01	1.43(1.12–1.82)	0.03
8 or more	65/290 (22.4)	2.99(2.09–4.27)	<0.01	1.53(1.04–2.24)	<0.01
History of COVID-19 related symptoms
Symptoms at any time since 1st Jan 2020
No symptoms	130/1589 (8.2)	Ref		Ref	<0.01
Symptomatic	305/1006 (30.3)	4.51(3.62–5.61)	<0.01	4.3(3.43–5.38)	<0.01
Not known	36/310 (11.6)	1.25(0.85–1.84)	0.26	1.05(0.71–1.57)	0.80
Symptomatic before or after starting university
Before	89/453 (19.6)	Ref		Ref
After	244/553 (44.1)	3.15(2.35–4.21)	<0.01	2.57(1.89–3.49)	<0.01
Confirmed case in accommodation
No confirmed case	186/1874 (9.9)	Ref		Ref
Confirmed case	310/866 (35.8)	4.52(3.67–5.58)	<0.01	3.57(2.86–4.44)	<0.01
Not Known	22/165 (13.3)	1.22(0.72–2.06)	0.45	0.95(0.58–1.56)	0.83

Adjusted for sex, age, ethnicity, living in halls of residence.

Adjusted for sex, age, ethnicity

OR = odds ratio; CI = confidence interval

Univariable and Multivariable models included university as a random effect.

When assessing the sharing of facilities in the different accommodation types, the odds of seropositivity increased with the number of individuals sharing a kitchen (sharing with 4 to 7 individuals, OR 1.92, 95%CI 1.53–2.42; sharing with 8 or more individuals OR 2.99, 95% CI 2.09–4.27, compared to sharing with 0–3 individuals). Those sharing a bathroom, however, had lower odds of seropositivity compared to those who didn't share a bathroom (OR 0.4, 95 CI% 0.4–0.5). In the multivariable logistic regression model, these associations also remained independently significant (Table 2).

Halls of residence – subgroup analyses

Subgroup analysis of those who lived in halls of residence (n = 697) found that living in a hall with larger numbers of residents was associated with higher seropositivity, although this association was not statistically significant (Table 3 ). A similar pattern was also seen with students sharing a kitchen, with the odds of seropositivity increasing with a greater number of individuals sharing a kitchen. This association was, however, only statistically significant in the multivariable model. Sharing a bedroom increased the odds of being seropositive (OR 3.8, 95% CI 1.1–13.1) but sharing a bathroom lowered the risk (OR 0.6, 95% CI 0.3–0.9).

Table 3

Potential risk factors for students living in halls of residence.

Variable	Seropositiven/N (%)	UnivariableregressionOR (95% CI)	P value	Multivariable regressionaOR (95% CI)	AdjustedP value
Gender
Male	92/273 (33.7)
Female	128/421 (30.4)	0.74(0.51–1.08)	0.12	0.63(0.43–0.93)	0.02
Prefer not to say	1/3 (33.3)	1.83(0.12–28.97)	0.67	2.58(0.12–55.72)	0.54
Age group
23–25 years	176/443 (39.7)	Ref		Ref
20–22 years	41/218 (18.8)	2.22(0.68–7.17)	0.18	2.06(0.63–6.72)	0.23
17–19 years	4/36 (11.1)	3.52(1.13–11.02)	0.03	3.1(0.97–9.91)	0.06
Ethnicity
White	195/596 (32.7)	Ref		Ref
Black	3/10 (30)	2.24(0.46–11.01)	0.32	2.65(0.53–13.28)	0.24
Asian	13/48 (27.1)	1.29(0.6–2.78)	0.51	1.19(0.54–2.58)	0.67
Mixed	9/33 (27.3)	0.71(0.29–1.72)	0.45	0.79(0.33–1.93)	0.61
Other	1/10 (10.0)	0.17(0.02–1.46)	0.11	0.18(0.02–1.58)	0.12
Hall size
Small (<300)	42/196 (21.4)	Ref		Ref
Medium (300–699)	103/331 (31.1)	1.46(0.76–2.78)	0.25	1.46(0.75–2.86)	0.27
Large (700+)	76/170 (44.7)	2.04(0.97–4.3)	0.06	2.06(0.99–4.29)	0.05
Sharing facilities
No. of individuals student shares kitchen with
0–3	26/83 (31.3)	Ref		Ref
4 to 7	145/413 (35.1)	1.5(0.82–2.73)	0.19	1.57(0.84–2.93)	0.16
8+	50/201 (24.9)	1.9(0.9–4.01)	0.10	2.35(1.1–5.01)	0.03
Share bathroom
No	163/435 (37.5)	Ref		Ref
Yes	58/262 (22.1)	0.55(0.32–0.93)	0.03	0.43(0.24–0.77)	<0.01
Share bedroom
No	214/677 (31.6)	Ref		Ref
Yes	7/20 (35.0)	3.84(1.13–13.06)	0.03	7.65(2.15–27.25)	<0.01
Case rate in halls of residence (self-report)
<8%	50/184 (27.2)	Ref		Ref
8–20%	101/206 (49)	2.28(1.13–4.56)	0.02	2.54(1.53–4.23)	<0.01
20%+	35/71 (49.3)	2.81(1.1–7.16)	0.03	2.25(1.16–4.35)	0.02
Unknown	35/236 (14.8)	–	–	–	–
Confirmed case in accommodation
No confirmed case	52/297 (17.5)	Ref		Ref
Confirmed case	156/323 (48.3)	3.02(1.96–4.65)	<0.01	2.75(1.77–4.27)	<0.01
Not known	13/77 (16.9)	0.79(0.38–1.62)	0.51	0.74(0.35–1.57)	0.43

All univariable estimates include individual hall of residence nested within University accounted for using a hierarchical mixed effects model

bAll multivariable estimates are adjusted for sex, age group, ethnicity, hall size, kitchen sharing, shared bathroom, shared bedroom, with individual hall of residence nested within University accounted for using a hierarchical mixed effects model

OR = odds ratio; CI = confidence interval.

For individuals who lived in halls of residence with available information on self-reported COVID-19 cases during the autumn term (n = 461), those who lived in halls of residence with 8–20% (OR 2.3, 95% CI 1.1–4.6) or >20% (OR 2.8, 95% CI 1.1–7.2) self-reported case rate had significantly higher odds of being seropositive compared to students living in halls of residence with <8% self-reported case rate. These associations remained statistically significant in the multivariable model.

Within halls of residence, students who reported a confirmed case in their accommodation setting had greater odds of testing positive for antibodies compared to those who didn't report a confirmed case in their accommodation (OR 3.02, 95% CI 1.96–4.65). This association remained in the multivariable model but was attenuated (OR 2.75, 95% CI 1.77–4.27).

Discussion

This cross-sectional UK study of SARS-CoV-2 antibody seroprevalence among the university student population found that 17.8% of university students had evidence of prior infection with SARS-CoV-2 by December 2020. This is higher than the seroprevalence reported by Office for National Statistics study of individuals over 16 years of age from England in December 2020 (12.1%, 95% CI: 11.6%−12.7%).

We observed a large variation in seropositivity rates between universities, ranging from 7.6% to 29.7%. When compared with blood donors aged 17–24 years in England during Weeks 46 to 51 (the only available data source in England with seroprevalence reported by region and age group), three of five universities had higher seroprevalence compared to their respective regional blood donor prevalence, although these differences were not statistically significant. Factors that may contribute to the observed variation between universities include differences in student populations including proportions living in university halls of residence, history of confirmed COVID-19 infection or COVID-19 related symptoms, as well as the size and duration of outbreaks during the autumn term. Seropositivity is also likely to be different in campus compared to city-integrated universities in terms of increased contact between the students and mixing with the general population, respectively.

Seropositivity was significantly associated with younger students, especially first year undergraduates, those living in halls of residence and those who shared a kitchen with a greater number of fellow students. Intriguingly, those who shared a bathroom had lower odds of antibody positivity compared to those who didn't share a bathroom even after adjusting for accommodation type. Sharing a kitchen may be an important factor for transmission due to the higher degree of close proximity interactions and potential sharing of utensils within the setting. A recent case study published by the Office of National Statistics also found that the risk of SARS-CoV-2 infection in two universities was greater in residential settings such as halls of residence, with little evidence of virus spread during face-to-face teaching in classrooms and lecture theatres.

Data on SARS-CoV-2 antibody prevalence amongst the university population are limited. A seroprevalence study in a Los Angeles university student population in May 2020 found antibody positivity rates of only 4.0%, similar to the community seroprevalence at the time. The low seroprevalence is likely explained by the stay at home order with closure of the physical university campus in March 2020. When compared with other educational settings such as primary schools at the end of the autumn term 2020 in England (10.4%; 95% CI 8.8–12.3), including 8.7% (31/358; 95% CI 6.2–12.1) of students and 11.2% (96/858; 95% CI 9.2–13.5) of staff), antibody seroprevalence among university students was higher.

We used SARS-CoV-2 antibodies to assess prior infection, which captures asymptomatic, symptomatic and mild, transient infections even if the individuals did not have a confirmatory PCR test. Serology also provides a cumulative measure of infection rates within an institutional setting, thus providing a more accurate representation of the true burden and spread of infection. For this study, we primarily used the Abbott assay which detects N-antibodies within 7–14 days infection, has a high sensitivity and specificity and detects antibodies earlier than other antibody assays, particularly those that measure SARS-CoV-2 spike protein antibodies which take longer to develop after infection. The very high seropositivity rates among students living in halls of residence with high self-reported case rates (>8%) during the autumn term highlights the ability of the virus to spread rapidly in closed settings, as has been demonstrated in care homes, prisons, and cruise ships. Public health interventions should target early identification, testing, confirmation and isolation of suspected cases, potentially through rapid mass testing, and implementation of infection control measures, to interrupt transmission and control the spread of the virus in such settings.

At the same time, however, less than one in five university students overall had SARS-CoV-2 antibodies, indicating that the majority of this population remains susceptible to future SARS-coV-2 infections and outbreaks when they return to campus.

The strength of this study was the large number of participants recruited rapidly in five universities across England. The demographics of the recruited cohort is similar to the UK higher education student population in 2018/19, reported to be 57% female and 76% of white ethnicity. Furthermore, once recruited, we achieved a high rate of return of blood samples, including 93% that had sufficient volume for antibody testing using a commercial assay, highlighting the willingness of students to participate in the study and demonstrating the acceptability of the Tasso device as a blood collection device for serosurveys.

The main limitation of the study is the convenience sampling strategy adopted. Due to the urgency of this work close to the end of the academic term, the study was open to all students who were 25 or under but the characteristics of those who took part – and, therefore, risk factors such as household contacts– may be different to those who did not take part. Furthermore, many students had already returned to their family home prior to the beginning of our study and, therefore, the sample may not be entirely representative of the wider student population. The recruitment model adopted by University C and D could also introduce bias as only students that were booked for mass lateral flow device (LFD) testing were targeted. Mass LFD testing programmes, for example, excluded students who were confirmed PCR positive in the last 90 days. It is not known how generalizable these findings may be to other university populations as the size and configuration of universities across the country are variable, influencing contact patterns and thus potential spread of infection.

Our findings in December 2020, however, do indicate that a large proportion of the student population remain susceptible to infection despite large outbreaks reported in each of these participating universities during the autumn term. We have also identified an important public health need to support universities with early identification and isolation of suspected cases and rapid implementation of infection control measures to interrupt the spread the virus and prevent large outbreaks in halls of residence. With the recent emergence of highly transmissible SARS-CoV-2 variants of concern, too, ongoing surveillance including serosurveillance will play a critical role in monitoring infection and transmission of SARS-CoV-2 in educational settings, including universities, when they re-open.

Declarations of Competing Interest

None.

Data sharing

Applications for relevant anonymised data should be submitted to the Public Health England Office for Data Release.

CRediT authorship contribution statement

Amoolya Vusirikala: Conceptualization, Methodology, Writing - original draft, Formal analysis, Project administration, Writing - review & editing. Heather Whitaker: Writing - original draft, Formal analysis, Project administration, Writing - review & editing. Samuel Jones: Project administration, Writing - review & editing. Elise Tessier: Project administration, Writing - review & editing. Ray Borrow: Project administration, Writing - review & editing. Ezra Linley: Project administration, Writing - review & editing. Katja Hoschler: Methodology, Project administration, Writing - review & editing. Frances Baawuah: Conceptualization, Project administration, Writing - review & editing. Shazaad Ahmad: Project administration, Writing - review & editing. Nick Andrews: Project administration, Writing - review & editing. Mary Ramsay: Conceptualization, Project administration, Writing - review & editing. Shamez N Ladhani: Conceptualization, Project administration, Writing - review & editing. Kevin E Brown: Conceptualization, Methodology, Writing - original draft, Project administration, Writing - review & editing. Gayatri Amirthalingam: Conceptualization, Methodology, Writing - original draft, Project administration, Writing - review & editing.